T. Nakazawa et al., PRELIMINARY EXPERIMENTAL-STUDY ABOUT THE FEASIBILITY OF COMBINING PULSATILE CARDIOPULMONARY SUPPORT SYSTEM AND A MEMBRANE-OXYGENATOR, International journal of artificial organs, 19(10), 1996, pp. 597-604
A cardiopulmonary support (CPS) device that incorporated a pneumatic v
entricular assist device (VAD) and a membrane oxygenator was developed
for the support of patients with profound heart and/or respiratory fa
ilure. This device has an advantage of being both a pulsatile assist d
evice and membrane oxygenator A ''triple flow'' regulator was included
in this system to control the blood flow through the oxygenator The p
urpose of this study was to clarify the efficacy of this system in sup
porting an animal model with combined cardiac and respiratory failure.
In vitro tests showed 3.7 L/min of pump flow under 1.6 L/min of oxyge
n supply to the oxygenator even though there was a 50% clamp of a ''tr
iple flow'' regulator with sufficient pulsatility. In 14 acute canine
experiments, cardiogenic shock and acute respiratory failure were intr
oduced by coronary ligation and mechanical hypoventilation simultaneou
sly The pump flow was maintaned at 1.95 - 0.6 L/min (average 1.2 L/min
) and the driving pressure of the pump was controlled between 200 and
300 mmHg positive pressure and -20 to -50 mmHg negative pressure. The
driving rate was fixed at 100 bpm and systolic/diastolic ratio was con
trolled between 35-50%. The canines were divided into control group (n
=4) and pumped group (drained from the right atrium n=7, drained from
the left atrium n=3). By using CPS system, flow and aortic pressure re
covered to the initial baseline level. Without this support, the canin
e model could not maintain systemic circulation. In the group drained
from right atrium, central venous pressure decreased with the device f
rom 13.9+/-2.4 to 5.6+/-1.4 cm H2O (p<0.01), returned to the initial l
evel without this device (p<0.01). In the group drained from left atri
um, pulmonary capillary wedge pressure decreased from 37.9+/-4.6 to 20
.8+/-5.7 mmHg (p<0.01), and returned to the initial level without the
device, arterial oxygen tension levels increased (p<0.01), and also ar
terial oxygen saturation levels recovered (p<0.01). The results sugges
t that the current model of the pulsatile CPS has a potential to suppo
rt the animal model with combined cardiac and respiratory failure.